Julian Jamie Freen-van Heeren (Julian J Freen-Van Heeren, Julian J Freen-van Heeren)

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 17

Top Topics

Dendritic Cells

Immune Response

Top Venues

Cytometry. Part A : the journal of the International Society for Analytical Cytology

European journal of immunology

Biotech (Basel (Switzerland))

This page only lists publications with an associated author ORCID identifier.

Publications

Rianne Opstelten, Julian Jamie Freen-van Heeren
CLASH of the Titans: How CAR-T Cells Can Triumph Over Tumors. The CRISPR journal (2023)
Julian Jamie Freen-van Heeren
Combining CRISPR with Flow-FISH to Study CRISPR-Mediated Genome Perturbation. Cytometry. Part A : the journal of the International Society for Analytical Cytology (2023)
Julian Jamie Freen-van Heeren, Rianne Opstelten
Age is just a number: long-lasting T-cell immunity can span several lifetimes. Immunology and cell biology (2023)
Julian Jamie Freen-van Heeren
Investigating EBV biology with Flow-FISH: Implications for EBV-mediated malignancies and the treatment thereof. Cytometry. Part A : the journal of the International Society for Analytical Cytology (2022)
Ammarina Beumer-Chuwonpad, Floris P J van Alphen, Natasja A M Kragten, Julian Jamie Freen-van Heeren, Maria Rodriguez Gomez, Arthur J Verhoeven, Maartje van den Biggelaar, Klaas P J M van Gisbergen
Memory CD8 + T cells upregulate glycolysis and effector functions under limiting oxygen conditions. European journal of immunology (2022)
Julian Jamie Freen-van Heeren
FISHing for COVID-19: Studying SARS-CoV-2 with single-molecule FISH and flow-FISH. Cytometry. Part A : the journal of the International Society for Analytical Cytology (2022)
Julian Jamie Freen-van Heeren
Closing the Door with CRISPR: Genome Editing of CCR5 and CXCR4 as a Potential Curative Solution for HIV. Biotech (Basel (Switzerland)) 11 (3) (2022)
Julian Jamie Freen-van Heeren
Harnessing high-throughput flow cytometric protein and RNA detection to enhance TIL therapy. Cytometry. Part A : the journal of the International Society for Analytical Cytology 99 (8) (2021)
Julian Jamie Freen-van Heeren
Post-transcriptional control of T-cell cytokine production: Implications for cancer therapy. Immunology 164 (1) (2021)
Julian Jamie Freen-van Heeren
Toll-like receptor-2/7-mediated T cell activation: An innate potential to augment CD8+ T cell cytokine production. Scandinavian journal of immunology 93 (5) (2021)
Julian Jamie Freen-van Heeren
Exploiting HIV-1 tropism to target CD4+ T cells for CRISPR. Immunology and cell biology 99 (7) (2021)
Julian Jamie Freen-van Heeren
Flow-FISH as a Tool for Studying Bacteria, Fungi and Viruses. Biotech (Basel (Switzerland)) 10 (4) (2021)
Julian Jamie Freen-van Heeren
Addressing HIV-1 latency with Flow-FISH: Finding, characterizing and targeting HIV-1 infected cells. Cytometry. Part A : the journal of the International Society for Analytical Cytology 99 (9) (2021)
Julian Jamie Freen-van Heeren, Branka Popović, Aurélie Guislain, Monika C Wolkers
Human T cells employ conserved AU-rich elements to fine-tune IFN-γ production. European journal of immunology 50 (7) (2020)
Rosa de Groot, Marleen M Van Loenen, Aurelie Guislain, Benoit P Nicolet, Julian Jamie Freen-van Heeren, Onno J H M Verhagen, Michel van den Heuvel, Jeroen De Jong, Patrick Burger, C Ellen Van Der Schoot, Robbert M Spaapen, Derk Amsen, John B A G Haanen, Kim Monkhorst, Koen J Hartemink, Monika C Wolkers
Polyfunctional tumor-reactive T cells are effectively expanded from non-small cell lung cancers, and correlate with an immune-engaged T cell profile. Oncoimmunology 8 (11) (2019)
Fiamma Salerno, Aurelie Guislain, Julian Jamie Freen-van Heeren, Benoit P Nicolet, Howard A Young, Monika C Wolkers
Critical role of post-transcriptional regulation for IFN-γ in tumor-infiltrating T cells. Oncoimmunology 8 (2) (2018)
Fiamma Salerno, Julian Jamie Freen-van Heeren, Aurelie Guislain, Benoit P Nicolet, Monika C Wolkers
Costimulation through TLR2 Drives Polyfunctional CD8+ T Cell Responses. Journal of immunology (Baltimore, Md. : 1950) 202 (3) (2018)